PNC-27 5mg

£34.90

PNC-27 is a p53-derived peptide designed for experimental investigation of p53-associated signalling and peptide–membrane interaction mechanisms.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: 1159861-00-3
  • Peptide Type: Synthetic p53-derived amphipathic peptide

In stock

Add to Cart
OP Labs PNC-27 5mg research peptide in glass vial
PNC-27 5mg
£34.90

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support
  • Guaranteed safe checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at ≥ 99% purity
  • Storage: –20 °C long term; 2–8 °C short term
  • Sold for research purposes only

PNC-27

Synonyms / Designations: PNC-27, p53-derived peptide, HDM-2–binding peptide
CAS Number: 1159861-00-3
Molecular Formula: C188H293N53O44S
Molecular Weight: 4031.72 g/mol
Peptide Classification: Synthetic p53-derived peptide; amphipathic membrane-active research peptide
Purity: ≥ 99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Pack Size: 5 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in sterile water and buffered aqueous solutions

Description & Mechanism

PNC-27 is a synthetic peptide derived from the HDM-2–binding domain of the p53 protein, conjugated to a membrane-penetrating leader sequence. It was developed as a structurally defined research tool to investigate peptide–membrane interactions and p53-associated signalling mechanisms.

In biochemical and cellular research models, PNC-27 has been shown to interact with membrane-associated HDM-2 in certain cell lines, leading to membrane pore formation. Experimental studies focus on peptide–membrane interactions and downstream signalling effects under controlled conditions. Observed effects depend on experimental design, concentration, and model system.

Applications in Research

• Investigation of p53-related signalling mechanisms
• Studies of peptide-induced membrane disruption
• In vitro cytotoxicity and membrane interaction assays
• Use as a reference compound in peptide-based membrane-disruption research

Specifications Summary

Purity: ≥ 99%
Appearance: White to off-white lyophilised powder
Peptide Type: Synthetic p53-derived peptide
Molecular Weight: 4031.72 g/mol
Solubility: Water, buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light
Pack Size: 5 mg

Precautions & Notes

• Experimental behaviour of PNC-27 is influenced by membrane composition, peptide concentration, and model system
• Peptide is membrane-active in cell-based models and should be handled with care
• Not intended to infer clinical safety or therapeutic use
• Appropriate controls are essential in cytotoxicity studies
• Intended strictly for laboratory research use; not for human or veterinary application

References

Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature, 2000.
https://pubmed.ncbi.nlm.nih.gov/11099028/

Keywords: PNC-27, p53 Peptide, Research Peptide, HDM-2 Binding Peptide, Synthetic Research Peptide